drugset / Trial / NCT00369174
Rosiglitazone Maleate in Treating Patients With Oral Leukoplakia
NaSingle-groupOpen-labelPrevention
Summary
This phase II trial is studying how well rosiglitazone works in preventing oral cancer in patients with oral leukoplakia. Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of rosiglitazone may keep cancer from forming in patients with oral leukoplakia
Timeline
- Start
- 2006-06
- Primary completion
- 2007-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosiglitazone | Small molecule | 8 mg | Oral |